Catalog Peptides Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017-2021 and Forecast 2022-2028

$ PRICE - $ 3,000.00$ 8,900.00

Catalog Peptides Market By Type (Cyclic, Calcitonin gene related, Caspase related, Amyloid, Adrenomedullin, Amylin, Tau, Cosmetic, Anti-microbial, GPCR and Others), By Application (Commercial, Academic research, Therapeutics), By End User (Pharmaceutical and biotechnology companies, CRO’s &CMO’s, Academic and research institute), and Geography (North America, Latin America, Europe, Asia Pacific and Middle East and Africa)

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail
SKU: N/A Category:

Report

Description

Catalog peptides market was valued at US$ 235.59 million in 2020 and is projected to grow US$ 403.75 million at a CAGR of 8% by 2027. The catalogue peptide market is witnessing growth due to technological advances that aid in the cost-effective manufacture of peptides. Previously, peptides were synthesized from natural sources such as porcine-derived adrenocorticotropic hormone (ACTH) or bovine pituitary, and bovine or canine pancreatic insulin. Growing research activities to address unmet medical needs in various therapeutic areas, raising the burden of chronic diseases and increasing investment and funding for protein-based research are among the key factors driving the market growth. Nevertheless, the absence of a coherent collection of regulations restrains business development. This study analyses the global catalog peptides market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market. In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across region and consumer unmet needs. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in Catalog peptides products.

 

key Developments:

In February 2017 to expand its product portfolio by incorporating proteins, antibodies and enzyme-linked immunosorbent assays (ELISA) into GenWay’s product portfolio and to become a key provider of proteomic solutions on the market.

In January 2017, the PolyPeptide Group announced the completion of its acquisition of the peptides business and operations of Lonza in Braine-l’Alleud, Belgium.

Catalog Peptides Market

MARKET SUMMARY
-
8% CAGR
  • Study Period– 2021 – 2027
  • Base Year– 2020
  • CAGR– 8%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Catalog Peptides Market Analysis

  • The catalog peptides market report provides a comprehensive outlook on catalog peptides worldwide with a specific focus on the key region such as North America, Europe, Asia Pacific, South America, the Middle East, and Africa.
  • The report on the global catalog peptides market gives historical, current and future market size (US$ Mn) on the basis of type, end-user, application, and geography.
Key Players
  • PolyPeptide Group
  • GL Biochem Ltd.
  • CPC Scientific Inc.
  • Biomatik Corporation
  • Advanced ChemTech
  • Creative Peptides
Catalog Peptides Market Drivers and Restraints

Recently there has been an increase in the number of research activities undertaken, especially in the areas of drug development, antibody production, disease research, and therapy. The increased emphasis on these areas allows for the revealing of novel techniques, many of which involve peptide use and synthesis. The increase in the number of research activities can be attributed to the rising demand for catalogue peptides which further increases the market share of the global catalogue peptides.


North-America Got Significant Share

Catalog Peptides Market Regional Analysis

North America is predicted to have the largest share of the Nucleic Acid Amplification Testing market by 2027, and it is expected to grow at a rapid pace in the following years. Because of improved healthcare infrastructure and the increased prevalence of infectious diseases, the United States is predicted to be the largest nucleic acid amplification testing market. NAAT was deployed in Canada by the Canadian Blood Services, and it is helping to ensure a safer blood supply by detecting tiny quantities of viral genetic material.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The Catalog Peptides Market market report provides granular level information about the market size, regional market share, historic market (2017-2021), and forecast (2022-2028)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
Nucleic Acid Amplification Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

2021 is the base year, and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

North America is dominating the nucleic acid amplification testing market


Report

Table Of Content

1. Executive Summary
2. Global Catalog Peptide Market Introduction
2.1. Global Catalog Peptide Market – Taxonomy
2.2. Global Catalog Peptide Market –Definitions
2.2.1. By Peptide Type
2.2.2. By Disease Type
2.2.3. By Application
2.2.4. By End User
2.2.5. By Region
3. Global Catalog Peptide Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Global Catalog Peptide Market Dynamic Factors – Impact Analysis
3.6. Global Catalog Peptide Market – Competition Landscape
4. Global Catalog Peptide Market Analysis, 2017-2021 and Forecast, 2022-2028
4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Global Catalog Peptide Market, By Peptide Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1. Adrenomedullin
5.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. G-Protein-Coupled Receptors (GPCR)
5.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. Amyloid
5.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. Caspase Related
5.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Calcitonin Gene-Related
5.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
5.6. Cyclic
5.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.6.3. Market Opportunity Analysis
5.7. Amylin
5.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.7.3. Market Opportunity Analysis
5.8. Tau
5.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.8.3. Market Opportunity Analysis
5.9. Others
5.9.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
5.9.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.9.3. Market Opportunity Analysis
6. Global Catalog Peptide Market, By Disease Type, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1. Cancer and Apoptosis
6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Cardiovascular
6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Diabetes
6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Neuroscience
6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
6.5. Infectious Diseases
6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.5.3. Market Opportunity Analysis
6.6. Anti-inflammatory
6.6.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.6.3. Market Opportunity Analysis
6.7. Blood Disorders
6.7.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.7.3. Market Opportunity Analysis
6.8. Others
6.8.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
6.8.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.8.3. Market Opportunity Analysis
7. Global Catalog Peptide Market, By Application, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1. Antibody Production
7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Drug Discovery
7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Enzyme Profiling
7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Biomarker Discovery
7.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Global Catalog Peptide Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1. Pharmaceutical and Biotechnology Companies
8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.1.3. Market Opportunity Analysis
8.2. CROs and CMOs
8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.2.3. Market Opportunity Analysis
8.3. Academic and Research Institutes
8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
8.3.3. Market Opportunity Analysis
9. Global Catalog Peptide Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1. North America
9.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.1.3. Market Opportunity Analysis
9.2. Europe
9.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.2.3. Market Opportunity Analysis
9.3. Asia-Pacific
9.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.3.3. Market Opportunity Analysis
9.4. Latin America
9.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.4.3. Market Opportunity Analysis
9.5. Middle East and Africa
9.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
9.5.3. Market Opportunity Analysis
9.6. Global Catalog Peptide Market – Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Region, 2022-2028
10. North America Catalog Peptide Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
10.1. Peptide Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.1.1. Adrenomedullin
10.1.2. G-Protein-Coupled Receptors (GPCR)
10.1.3. Amyloid
10.1.4. Caspase Related
10.1.5. Calcitonin Gene-Related
10.1.6. Cyclic
10.1.7. Amylin
10.1.8. Tau
10.1.9. Others
10.2. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
10.2.1. Cancer and Apoptosis
10.2.2. Cardiovascular
10.2.3. Diabetes
10.2.4. Neuroscience
10.2.5. Infectious Diseases
10.2.6. Anti-inflammatory
10.2.7. Blood Disorders
10.2.8. Others
10.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.3.1. Antibody Production
10.3.2. Drug Discovery
10.3.3. Enzyme Profiling
10.3.4. Biomarker Discovery
10.3.5. Others
10.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
10.4.1. Pharmaceutical and Biotechnology Companies
10.4.2. CROs and CMOs
10.4.3. Academic and Research Institutes
10.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
10.5.1. USA
10.5.2. Canada
10.6. North America Catalog Peptide Market – Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2022-2028
10.7. North America Catalog Peptide Market Dynamics – Trends
11. Europe Catalog Peptide Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
11.1. Peptide Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.1.1. Adrenomedullin
11.1.2. G-Protein-Coupled Receptors (GPCR)
11.1.3. Amyloid
11.1.4. Caspase Related
11.1.5. Calcitonin Gene-Related
11.1.6. Cyclic
11.1.7. Amylin
11.1.8. Tau
11.1.9. Others
11.2. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
11.2.1. Cancer and Apoptosis
11.2.2. Cardiovascular
11.2.3. Diabetes
11.2.4. Neuroscience
11.2.5. Infectious Diseases
11.2.6. Anti-inflammatory
11.2.7. Blood Disorders
11.2.8. Others
11.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.3.1. Antibody Production
11.3.2. Drug Discovery
11.3.3. Enzyme Profiling
11.3.4. Biomarker Discovery
11.3.5. Others
11.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
11.4.1. Pharmaceutical and Biotechnology Companies
11.4.2. CROs and CMOs
11.4.3. Academic and Research Institutes
11.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Russia
11.5.7. Rest of Europe
11.6. Europe Catalog Peptide Market – Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2022-2028
11.7. Europe Catalog Peptide Market Dynamics – Trends
12. Asia-Pacific Catalog Peptide Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
12.1. Peptide Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.1.1. Adrenomedullin
12.1.2. G-Protein-Coupled Receptors (GPCR)
12.1.3. Amyloid
12.1.4. Caspase Related
12.1.5. Calcitonin Gene-Related
12.1.6. Cyclic
12.1.7. Amylin
12.1.8. Tau
12.1.9. Others
12.2. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
12.2.1. Cancer and Apoptosis
12.2.2. Cardiovascular
12.2.3. Diabetes
12.2.4. Neuroscience
12.2.5. Infectious Diseases
12.2.6. Anti-inflammatory
12.2.7. Blood Disorders
12.2.8. Others
12.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.3.1. Antibody Production
12.3.2. Drug Discovery
12.3.3. Enzyme Profiling
12.3.4. Biomarker Discovery
12.3.5. Others
12.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
12.4.1. Pharmaceutical and Biotechnology Companies
12.4.2. CROs and CMOs
12.4.3. Academic and Research Institutes
12.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. ASEAN
12.5.5. Australia & New Zealand
12.5.6. Rest of Asia-Pacific
12.6. Asia-Pacific Catalog Peptide Market – Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2022-2028
12.7. Asia-Pacific Catalog Peptide Market Dynamics – Trends
13. Latin America Catalog Peptide Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
13.1. Peptide Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.1.1. Adrenomedullin
13.1.2. G-Protein-Coupled Receptors (GPCR)
13.1.3. Amyloid
13.1.4. Caspase Related
13.1.5. Calcitonin Gene-Related
13.1.6. Cyclic
13.1.7. Amylin
13.1.8. Tau
13.1.9. Others
13.2. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
13.2.1. Cancer and Apoptosis
13.2.2. Cardiovascular
13.2.3. Diabetes
13.2.4. Neuroscience
13.2.5. Infectious Diseases
13.2.6. Anti-inflammatory
13.2.7. Blood Disorders
13.2.8. Others
13.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.3.1. Antibody Production
13.3.2. Drug Discovery
13.3.3. Enzyme Profiling
13.3.4. Biomarker Discovery
13.3.5. Others
13.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
13.4.1. Pharmaceutical and Biotechnology Companies
13.4.2. CROs and CMOs
13.4.3. Academic and Research Institutes
13.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Catalog Peptide Market – Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2022-2028
13.7. Latin America Catalog Peptide Market Dynamics – Trends
14. Middle East and Africa Catalog Peptide Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, USD Mn)
14.1. Peptide Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.1.1. Adrenomedullin
14.1.2. G-Protein-Coupled Receptors (GPCR)
14.1.3. Amyloid
14.1.4. Caspase Related
14.1.5. Calcitonin Gene-Related
14.1.6. Cyclic
14.1.7. Amylin
14.1.8. Tau
14.1.9. Others
14.2. Disease Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
14.2.1. Cancer and Apoptosis
14.2.2. Cardiovascular
14.2.3. Diabetes
14.2.4. Neuroscience
14.2.5. Infectious Diseases
14.2.6. Anti-inflammatory
14.2.7. Blood Disorders
14.2.8. Others
14.3. Application Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.3.1. Antibody Production
14.3.2. Drug Discovery
14.3.3. Enzyme Profiling
14.3.4. Biomarker Discovery
14.3.5. Others
14.4. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
14.4.1. Pharmaceutical and Biotechnology Companies
14.4.2. CROs and CMOs
14.4.3. Academic and Research Institutes
14.5. Country Analysis 2017-2021 and Forecast 2022-2028 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
14.5.1. Gulf Cooperation Council (GCC) Countries
14.5.2. South Africa
14.5.3. Rest of MEA
14.6. MEA Catalog Peptide Market – Opportunity Analysis Index, By Peptide Type, Disease Type, Application, End User, and Country, 2022-2028
14.7. MEA Catalog Peptide Market Dynamics – Trends
15. Competition Landscape
15.1. Strategic Dashboard of Top Market Players
15.2. Company Profiles (Introduction, Financial Analysis, Key Offerings, Key Developments, Strategies, and SWOT Analysis)
15.2.1. Bachem AG
15.2.2. JPT Peptide Technologies GmbH
15.2.3. AAPPTEC
15.2.4. Kaneka Eurogentec S.A.
15.2.5. Biopeptek Pharmaceuticals LLC
15.2.6. Vivitide, LLC
15.2.7. Abbiotec Inc.
15.2.8. Auspep Pty Ltd.
15.2.9. Peptides International Inc.
15.2.10. Thermo Fisher Scientific Inc.
15.2.11. GenScript Biotech Corporation
15.2.12. Creative Peptides
15.2.13. KareBay Biochem Inc.
15.2.14. Ontores Biotechnologies Inc.
15.2.15. Severn Biotech Ltd.
16. Research Methodology
17. Key Assumptions and Acronyms

Report

Company Profile

  • PolyPeptide Group
  • CSBio
  • GL Biochem Ltd.
  • CPC Scientific Inc.
  • Peptides International Ltd.
  • Applied Biological Materials Inc.
  • Biomatik Corporation
  • Bio-Synthesis Inc.
  • Advanced ChemTech
  • Creative Peptides

Description

Catalog peptides market was valued at US$ 235.59 million in 2020 and is projected to grow US$ 403.75 million at a CAGR of 8% by 2027. The catalogue peptide market is witnessing growth due to technological advances that aid in the cost-effective manufacture of peptides. Previously, peptides were synthesized from natural sources such as porcine-derived adrenocorticotropic hormone (ACTH) or bovine pituitary, and bovine or canine pancreatic insulin. Growing research activities to address unmet medical needs in various therapeutic areas, raising the burden of chronic diseases and increasing investment and funding for protein-based research are among the key factors driving the market growth. Nevertheless, the absence of a coherent collection of regulations restrains business development. This study analyses the global catalog peptides market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market. In addition, PBI has analyzed the global market to better equip customers with possible investment opportunities across region and consumer unmet needs. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in Catalog peptides products.

 

key Developments:

In February 2017 to expand its product portfolio by incorporating proteins, antibodies and enzyme-linked immunosorbent assays (ELISA) into GenWay’s product portfolio and to become a key provider of proteomic solutions on the market.

In January 2017, the PolyPeptide Group announced the completion of its acquisition of the peptides business and operations of Lonza in Braine-l’Alleud, Belgium.

ASIA PACIFIC OFFICE

Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad - 500072

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX